EU Report Shows Drop In Pay-For-Delay Deals

Law360, New York (July 6, 2010, 4:03 PM EDT) -- The number of pay-for-delay patent settlements and other agreements in the pharmaceutical industry that may run afoul of European competition law has dropped significantly over the past year and a half, according to a new report from the European Commission.

A year after the antitrust watchdog released the results of its first wide-ranging inquiry into patent settlements in the pharmaceutical sector, a report released Monday showed that the potentially troubling settlements had dropped to roughly 10 percent of all patent settlements in the industry from July...
To view the full article, register now.